<?xml version="1.0" encoding="UTF-8"?>
<ref id="B172-nutrients-10-01662" class="ref">
 <label class="label">172.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Davidson</surname>
    <given-names class="given-names">M.H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Johnson</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Rooney</surname>
    <given-names class="given-names">M.W.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kyle</surname>
    <given-names class="given-names">M.L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kling</surname>
    <given-names class="given-names">D.F.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova
   <sup class="sup">®</sup> compared to Lovaza
   <sup class="sup">®</sup> in a pharmacokinetic single-dose evaluation) study
  </article-title>
  <source class="source">J. Clin. Lipidol.</source>
  <year class="year">2012</year>
  <volume class="volume">6</volume>
  <fpage class="fpage">573</fpage>
  <lpage class="lpage">584</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.jacl.2012.01.002</pub-id>
  <?supplied-pmid 23312053?>
  <pub-id pub-id-type="pmid" class="pub-id">23312053</pub-id>
 </element-citation>
</ref>
